Surges of increased T cell reactivity to an encephalitogenic region of myelin proteolipid protein occur more often in patients with multiple sclerosis than in healthy subjects

Journal of Immunology

Volumn 165, Issue 9, 2000, Pages 5322-5331

  Pender, Michael P ^a,b   Csurhes, Peter A ^a   Greer, Judith M ^a   Mowat, Paul D ^b   Henderson, Robert D ^b   Cameron, Kaye D ^a,b   Purdie, David M ^c   McCombe, Pamela A ^a,b   Good, Michael F ^c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ENCEPHALITOGENIC PROTEIN; EPITOPE; GADOLINIUM; MYELIN; MYELIN BASIC PROTEIN; PROTEOLIPID PROTEIN; TETANUS TOXOID;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELAPSE; T LYMPHOCYTE ACTIVATION;

EID: 0034326642     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.9.5322     Document Type: Article

References (32)

1. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis
2. Multiple sclerosis
3. Increased immunoreactivity to two overlapping peptides of myelin proteolipid protein in multiple sclerosis
4. Identification and characterization of a second encephalitogenic determinant of myelin proteolipid protein. (residues 178-191) for SJL mice
5. Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein
6. T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans
7. Limiting dilution analysis of human T cells: A useful clinical tool
8. Quantitation of antigen-specific immune responses in human immunodeficiency virus (HIV)-infected individuals by limiting dilution analysis
9. Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals
10. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis
11. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
12. Mutation of the proteolipid protein gene PLP in a human X chromosome-linked myelin disorder
13. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species
14. The evaluation of limiting dilution assays
15. The effect of interferon-β on blood-brain barrier disruptions demonstrated by contrast-enhanced magnetic resonance imaging in relapsing-remitting multiple sclerosis
16. Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis
17. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients
18. A very high level of crossreactivity is an essential feature of the T-cell receptor
19. Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein
20. Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone
21. Episodic changes in T-cell frequencies to myelin basic protein in patients with multiple sclerosis
22. Cellular immune reactivity within the CNS
23. T-lymphocyte entry into the central nervous system
24. Genetically determined failure of activation-induced apoptosis of autoreactive T cells as a cause of multiple sclerosis
25. Apoptosis of αβ T lymphocytes in the nervous system in experimental autoimmune encephalomyelitis: Its possible implications for recovery and acquired tolerance
26. + encephalitogenic T cells
27. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis
28. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis: Pathogenetic and clinical implications
29. 1 lesion volumes in multiple sclerosis: Evidence for distinct mechanisms of lesion genesis?
30. Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions
31. Isolation and characterization of a novel oligodendrocyte-specific protein
32. Myelin-associated oligodendrocytic basic protein: Identification of an encephalitogenic epitope and association with multiple sclerosis